University of Kentucky

UKnowledge
Epidemiology and Environmental Health Faculty
Publications

Epidemiology and Environmental Health

1-17-2021

Estimating the Population Attributable Fraction of Asthma Due to
Electronic Cigarette Use and Other Risk Factors Using Kentucky
Behavioral Risk Factor Survey Data, 2016-2017
W. Jay Christian
University of Kentucky, jay.christian@uky.edu

Courtney J. Walker
University of Kentucky, courtney.walker@uky.edu

Follow this and additional works at: https://uknowledge.uky.edu/epidemiology_facpub
Part of the Epidemiology Commons, and the Substance Abuse and Addiction Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Christian, W. Jay and Walker, Courtney J., "Estimating the Population Attributable Fraction of Asthma Due
to Electronic Cigarette Use and Other Risk Factors Using Kentucky Behavioral Risk Factor Survey Data,
2016-2017" (2021). Epidemiology and Environmental Health Faculty Publications. 71.
https://uknowledge.uky.edu/epidemiology_facpub/71

This Article is brought to you for free and open access by the Epidemiology and Environmental Health at
UKnowledge. It has been accepted for inclusion in Epidemiology and Environmental Health Faculty Publications by
an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

Estimating the Population Attributable Fraction of Asthma Due to Electronic
Cigarette Use and Other Risk Factors Using Kentucky Behavioral Risk Factor
Survey Data, 2016-2017
Digital Object Identifier (DOI)
https://doi.org/10.1080/10826084.2020.1868002

Notes/Citation Information
Published in Substance Use & Misuse, v. 56, issue 3.
© 2021 The Author(s) This is an Open Access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivatives License (https://creativecommons.org/licenses/bync-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided
the original work is properly cited, and is not altered, transformed, or built upon in any way.

This article is available at UKnowledge: https://uknowledge.uky.edu/epidemiology_facpub/71

SUBSTANCE USE & MISUSE
https://doi.org/10.1080/10826084.2020.1868002
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Estimating the Population Attributable Fraction of Asthma Due to Electronic
Cigarette Use and Other Risk Factors Using Kentucky Behavioral Risk Factor
Survey Data, 2016–2017
W. Jay Christian and Courtney J. Walker
Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA
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ABSTRACT

Introduction: Electronic nicotine delivery systems ENDS have become popular in the United States
among both new users of nicotine and those seeking less harmful alternatives to traditional cigarettes. Users often perceive ENDS as being less harmful than traditional cigarettes. This study
investigated the relationship between use of ENDS and asthma in a representative sample of
adults. Methods: For this cross-sectional study, we used data from the Kentucky Behavioral Risk
Factor Surveillance System telephone survey data from 2016-2017. Using a weighted multivariable
logistic regression analysis, we identified important covariates to adjust for to calculate the population attributable fraction (PAF) of asthma due to ENDS and other modifiable risk factors factors
(cigarette use, obesity, education, and employment). The confidence intervals for the PAFs were
estimated using bootstrap methods of variance estimation. Results: We found that 10.6% of those
aged 18-30 reported currently had asthma. After adjusting for noted covariates, ENDS use did not
significantly increase the odds of asthma. In the final PAF model, the PAF of asthma due to ENDS
was 0.4% (95% CI: -5.41, 6.21). Conclusion: While these findings suggest only modest effects of
ENDS use on asthma prevalence, future research including older age groups and more long-term
users might produce different results.

Introduction
Electronic cigarettes (also known as ENDS [electronic nicotine delivery systems], “e-cigarettes,” or “e-cigs”) have been
rapidly adopted in the United States, perhaps because they
have been promoted as a healthy alternative to traditional
cigarette consumption and a tool for smoking cessation
(Coleman et al., 2017; Ned Sharpless, 2019). Coleman and
colleagues found in a recent assessment of PATH data
(Population Assessment of Tobacco and Health) that among
all user groups (current, former, and never cigarette smokers) the perception of lack of harm was one of the most
common reasons for initiation. Former cigarette smokers
also reported use of e-cigarettes as a means of smoking cessation, which appears to be a component in their growing
popularity (Coleman et al., 2017). McMillen and colleagues
found that adult usage increased by over 11% from
2011–2013, with current cigarette smokers being the majority of users, but nonsmokers also experiencing an increase
in engagement (Coleman et al., 2017; McMillen et al., 2015;
National Center for Chronic Disease P et al., 2016). It is
important to note, however, that highest rates of use are
among adolescents and young adults (Carroll Chapman &
Wu, 2014).
CONTACT W. Jay Christian
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The aerosols (“vapor”) from e-cigarettes nevertheless
share some chemical components with traditional cigarettes
(e.g. nicotine), even though they do not rely on combustion.
Specific design elements vary among manufacturers, but
ENDS generally include three components—a heating element, a battery (often a rechargeable lithium battery), and a
reservoir for the liquid that is aerosolized for the user to
inhale (CDC.gov, 2020a; Grana et al., 2014). The liquid typically consists of nicotine, some flavoring, and a solvent
(such as propylene glycol or vegetable glycerin) (Goniewicz
et al., 2015). Many of the flavoring compounds used in these
products, although perhaps noted safe for dermal or oral
exposure, may have little to no assessments for inhalation
(CDC.gov, 2020b; Grana et al., 2014). Other challenges
include labeling inaccuracies—which may not list all substances accurately, or omit them entirely. These inconsistences have been found when evaluating both the e-cigarette
solution as well as inhaled chemicals in puff-to-puff assessments (Cheng, 2014; Grana et al., 2014; Lisko et al., 2015;
National Center for Chronic Disease P et al., 2016). Limited
research suggests that solvent mixture could also impact the
physical characteristics of the aerosol, leading to the variation in findings currently seen in the literature (Zhang
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et al., 2013). Many researchers attribute documented variations to lack of quality control in both device and liquid
manufacturing (Cheng, 2014; Goniewicz et al., 2013; Grana
et al., 2014; McMillen et al., 2015).
Studies comparing nicotine levels in blood plasma
(CDC.gov, 2020a) and urine (Grana et al., 2014) of traditional and e-cigarette users have observed lower levels in ecigarette users. Other studies have found that harmful toxicants often present in traditional cigarettes, such as formaldehyde, acetaldehyde, and toluene, are present in lower
concentrations in both e-cigarettes solutions and the users
compared to traditional cigarettes and smokers (Grana et al.,
2014; Ratajczak et al., 2018). This is due to the combustion
process in traditional cigarettes, absent in e-cigarettes, that
generates many of the chemicals that are known to be harmful to respiratory health (Ratajczak et al., 2018).
Since e-cigarettes only became available to general consumers in, 2007 (McMillen et al., 2015), little is known about the
long-term effects of use. However, cross-sectional studies suggest that e-cigarette usage is associated with higher rates of
asthma, or asthma-like symptoms in both adults (Osei et al.,
2019; Wang et al., 2018; Wills et al., 2019) and teens (Kim
et al., 2017; Schweitzer et al., 2017; Wills et al., 2016).
Although some evidence suggests smokers who switch to e-cigarettes improve their respiratory function, preliminary studies
in teens indicate those who report asthma symptoms have a
higher prevalence of e-cigarette use compared to their peers
(Clapp & Jaspers, 2017; Polosa et al., 2014). A recent study by
Wills, using data from the Hawaii BRFSS, showed that e-cigarette use in adults is associated with a decline in respiratory
health compared to nonsmokers (Wills et al., 2019). Given that
asthma prevalence has been increasing, and the evidence suggesting that e-cigarette use is associated with asthma symptoms, this study seeks to quantify what proportion of asthma
cases in young adults (18–30) may be due to e-cigarette use—
either alone or in combination with combustible tobacco products (Centers for Disease Control (CDC), 2019).

Methods
This retrospective cross-sectional analysis of existing data
was evaluated by the University of Kentucky Institutional
Review Board and ruled exempt.
Data were obtained directly from the Kentucky
Behavioral Risk Factor Surveillance System (BRFSS) for the
study period, 2016–2017. The BRFSS is a random-digitdialed telephone survey, conducted among both mobile
phones and land-based telephones annually. It is funded by
the Centers for Disease Control and Prevention (CDC) but
administered and conducted by the states. Responses are
weighted to the population to allow for population-based
estimation of the prevalence of health conditions and
health-related behaviors. We focused on young adults
between the ages of 18–30 because this age group has been
shown to have the highest prevalence of e-cigarette use
(Coleman et al., 2017; McMillen et al., 2015).

Asthma and cigarette use
Asthma classification was self-reported; those who
responded affirmatively to “(Ever told) you that you had
asthma?” and “do you still have asthma” were classified as
having asthma (CDC, 2018). Current e-cigarette use was
ascertained by the question “Do you now use e-cigarettes or
other electronic vaping products every day, some days, or
not at all?” For traditional cigarettes, participants who
reported smoking at least 100 hundred cigarettes, and
responded that they smoked “every day” or “some days”
were considered current smokers. Those who reported they
had not smoking 100 cigarettes or who reported smoking
“not at all” were considered nonsmokers.

Other covariates
Employment was classified as employed (self-employed, or
employed for wages), non-working (out of work, retired, or
unable to work), or other (home-makers or students).
Participants with a BMI  30 were classified as obese, otherwise non-obese. Other covariates included education (less
than high school education, high school graduate, and some
college or above), gender (male, female), marital status
(married/long term relationship, divorced/separated, never
married), income (<$25k, $25–<$50k, >$50k), race (white
non-Hispanic, black non-Hispanic, and other [including
Hispanic]), and age, (continuous).

Statistical analysis
All variables were summarized with counts and percentages for
the overall sample and by current asthma status. Statistical differences among groups were assessed with chi-square tests.
Unadjusted and adjusted weighted logistic regression models
were used to identify key individual factors associated with
asthma. To calculate the population attributable fraction (PAF)
and variance estimation, adjusting for the survey weights, we
used a four-step SAS macro, developed and provided by
Herringa and colleagues (2015). First, we identified the risk
model, a logistic regression, and entered modifiable and nonmodifiable risk factors into the model. Using the macro, we
estimated the parameters using BRFSS survey weights. In the
third step, the macro calculated the population-weighted estimate of the PAF. In the third step, the macro calculated the
standard errors and confidence limits using the bootstrap variance estimation methods. Finally, the confidence limits for the
PAF were constructed. This method was repeated for each
modifiable risk factor (cigarette smoking, ENDS use, education,
and employment). For further detail on the process, please see
Heeringa and colleagues published work (Heeringa et al., 2015).
Data management and statistical analyses were performed
using SAS version 9.4 (SAS Institute, Cary, NC). We used
survey procedures to account for the complex sample survey
design when applicable, and statistical significance was based
on a p value <0.05.
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Table 1. Demographic characteristics and modifiable risk factors for asthma among those 18–30 years old BRFSS—2016–2017.

Current e-cigarette user
Not current e-cigarette smoker
Current e-cigarette smoker
Ever used e-cigarettes
Never used e-cigarettes
Ever used e-cigarettes
Current smoker
Not current smoker
Current smoker
Ever used cigarettes
Never used cigarettes
Ever used cigarettes
Obese
Not obese
Obese
Education
Less than High School
High School
Some college or technical degree
Bachelor’s degree or above
Employment
Employed (self or otherwise)
Non-working
Student/Homemaker
Gender
Female
Male
Income
<$25k
$25-<$50k
>$50
Race/Ethnicity
White, Non-Hispanic
Black, Non-Hispanic
Hispanic / Other race
Age
Mean (SD)
Median (Q1, Q3)
Minimum, Maximum

Asthma
(N 5253)

No Asthma
(N 5 2,107)

Total Participants
(N 5 2,387)

222 (90.6%)
23 (9.4%)

1860 (91.5%)
172 (8.5%)

2082 (91.4%)
195 (8.6%)

0.63

143 (58.4%)
102 (41.6%)

1206 (59.4%)
826 (40.6%)

1349 (59.2%)
928 (40.8%)

0.77

184 (74.5%)
63 (25.5%)

1597 (78.3%)
442 (21.7%)

1781 (77.9%)
505 (22.1%)

0.17

159 (64.4%)
88 (35.6%)

1388 (68.1%)
651 (31.9%)

1547 (67.7%)
739 (32.3%)

0.24

149 (66.8%)
74 (33.2%)

1454 (74.5%)
498 (25.5%)

1603 (73.7%)
572 (26.3%)

0.01

15
74
106
58

(5.9%)
(29.2%)
(41.9%)
(22.9%)

112
652
770
570

(5.3%)
(31.0%)
(36.6%)
(27.1%)

127
726
876
628

P-value

(5.4%)
(30.8%)
(37.2%)
(26.6%)

0.31

149 (59.4%)
31 (12.4%)
71 (28.3%)

1390 (66.7%)
176 (8.4%)
517 (24.8%)

1539 (65.9%)
207 (8.9%)
588 (25.2%)

0.03

170 (67.2%)
83 (32.8%)

964 (45.8%)
1143 (54.2%)

1134 (48.1%)
1226 (51.9%)

<0.01

72 (43.4%)
46 (27.7%)
48 (28.9%)

439 (29.1%)
426 (28.3%)
642 (42.6%)

511 (30.5%)
472 (28.2%)
690 (41.2%)

<0.01

201 (79.8%)
25 (9.9%)
26 (10.3%)

1767 (84.6%)
149 (7.1%)
173 (8.3%)

1968 (84.1%)
174 (7.4%)
199 (8.5%)

0.13

23.7 (3.84)
23 (20, 27)
18, 30

24.1 (3.78)
24 (21, 27)
18, 30

24 (3.79)
24 (21, 27)
18, 30

0.11

Results
There were a total of 2387 participants, 253 (10.6%) with
current asthma (Table 1). Of the total participants, 22.1%
reported currently smoking cigarettes and 8.6% were current
e-cigarette users. The majority of the sample was non-obese
(73.7%),
employed
(65.9%),
male
(51.9%),
and
white (84.1%).
Of those who currently had asthma, 25.5% were current
smokers, 41.6% had used ENDS devices, and 6.9% were dual
users. Those with asthma were more likely to be obese
(33.2%), female (67.2%), and live in a household with
<$25,000 income per year (43.4%). There was also a higher
percentage who were not working (12.4%) among those
with asthma, compared to those without (8.4%). For those
who reported not having asthma, 8.5% reported current
ENDS use and 40.6% reported using a device. The majority
of those without asthma did not currently smoke (78.3%)
and few reported ever trying cigarettes (31.9%).
Table 2 presents the unadjusted and adjusted odds for
individual factors associated with asthma. Neither e-cigarettes (AOR ¼ 1.05, p ¼ 0.9) nor cigarettes significantly
increased the odds (AOR ¼ 1.25, p ¼ 0.36), adjusting for
other covariates. However, those with a high school education had lower odds of asthma compared to those who had

less than high school education (AOR ¼ 0.38, p ¼ 0.01).
Males had 63% lower odds of asthma compared to females,
adjusting for other relative covariates (p < 0.01).
Table 3 summarizes the PAF and 95% confidence limits
for each modifiable risk factor. After controlling for asthma
risk factors (obesity, cigarette smoking, employment status,
gender, and education), the PAF of e-cigarettes on asthma
was 0.4% (95% CI 5.41, 6.21). The largest modifiable risk
factor, cigarette smoking was 2.67% (95% CI: 12.5, 16.6),
however it was not significant. Compared to those who did
not graduate high school, obtaining a high school degree
decreased the PAF of asthma, although this was not significant (PAR ¼ 36.1%, 95% CI: 78.2, 6.01).

Discussion
This study assessed individual characteristics associated with
increased odds of asthma and calculated the PAF of asthma
cases due to e-cigarette use, cigarette use, obesity, education,
and employment using survey weights adjusting for gender.
Our study found that a majority of Kentuckians aged 18–30
had ever used traditional cigarettes. A substantial but smaller
proportion (41%) had also tried e-cigarettes, but only 9%
reported currently using them. If Kentuckians in this age
group had never used ENDS, we estimate that 0.4% of
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Table 2. Weighted multivariate logistic regression for current asthma, adjusted for relevant risk factors using the BRFSS 2016–2017.
Unadjusted OR
Current ENDS user
Not ENDS user
ENDS user
Current Cigarette Smoker
Not a smoker
Smoker
Obese
Non-obese
Obese
Education
Less than a high school
High school
Some college or technical degree
BA or above
Employment
Not employed
Employed (self or otherwise)
Student/Homemaker
Race/Ethnicity
White
Black, Non-Hispanic
Hispanic / Other race
Gender
Female
Male
Age

OR

LCL

UCL

p-value

OR

LCL

UCL

p-value

Reference
1

0.52

1.91

1

Reference
1.06

0.5

2.21

0.89

Reference
1.54

0.98

2.42

0.06

Reference
1.13

0.69

1.84

0.63

Reference
1.24

0.82

1.87

0.31

Reference
0.99

0.62

1.56

0.96

Reference
0.49
0.54
0.4

0.24
0.26
0.19

1.02
1.11
0.87

0.06
0.09
<0.01

Reference
0.37
0.48
0.3

0.18
0.24
0.14

0.77
0.98
0.66

0.01
0.04
<0.01

Reference
0.44
0.44

0.24
0.22

0.82
0.87

0.01
0.02

Reference
0.59
0.41

0.32
0.2

1.07
0.84

0.08
0.01

Reference
1.2
1.04

0.64
0.53

2.26
2.02

0.57
0.91

Reference
1.16
1.15

0.57
0.54

2.39
2.45

0.68
0.72

Reference
0.39
1.01

0.26
0.96

0.59
1.07

<.0001
0.68

Reference
0.36
1

0.23
0.95

0.56
1.06

<0.01
<0.01

Table 3. Population attributable fraction (%) and 95% Confidence Interval for
modifiable risk factors for asthma among those aged 18–30,
BRFSS 2016–2017.
Current smoker
Current e-cigarette smoker
Obesity
Education
Less than High School
High School
Some college or technical degree
BA or above
Employment
Non-Working
Employed (self or otherwise)
Student/Homemaker

Adjusted OR

AF
2.67
0.40
0.04

LCL
12.47
5.41
9.39

UCL
16.59
6.21
9.48

Reference
36.11
33.31
20.83

78.23
73.24
39.52

6.01
6.63
2.14

Reference
31.57
25.61

83.57
43.47

20.42
7.76

asthma cases could have been prevented in those aged
18–30 in Kentucky (95% CI: 5.41, 6.21). This equates to
approximately 2890 cases, given the U.S. Census-estimated
number of Kentucky adults aged (18–29) range in 2017, and
the prevalence of asthma that we estimated for this age
range in Kentucky (Bureau USC, 2017).
Although the literature suggests obesity is a major risk
factor for asthma (Kim et al., 2017), we did not observe this
after adjustment for noted covariates. Furthermore, the PAF
of asthma for obesity was very low. We did, however, find a
strong negative association between asthma and educational
attainment, which does agree with what is already known
about associations between asthma and socioeconomic status
(Ellison-Loschmann et al., 2007). This might also partially
explain why, compared to those who were unemployed,
those who worked or were a student/homemaker had lower
prevalence of asthma.
Although the asthma PAF we observed for those aged
18–30 was not statistically significant, further work is still
needed. This study only included adults 18–30 years old,

who may not have been using these products long enough
to experience symptoms consistent with asthma.
Furthermore, use rates of ENDS might increase in older
age groups over the next few decades without substantial
intervention. This seems especially likely given research
showing that people begin using these products at younger
ages (Carroll Chapman & Wu, 2014; Evans-Polce
et al., 2020).
Given the noted lack of quality control in product manufacturing, wide variety of compounds used in these products, and lack of inhalation exposure assessment, the longterm health effects of ENDS use are unknown. Studies
assessing short-term health effects of ENDS use suggest that,
although less harmful than traditional cigarettes, users still
experience respiratory symptoms (Osei et al., 2019;
Schweitzer et al., 2017; Wang et al., 2018; Wills et al., 2019).
Furthermore, those with preexisting asthma may suffer more
immediate health effects, such as reduced pulmonary function and airway inflammation, compared to those without
asthma (Kotoulas et al., 2020). After adjusting for other
covariates, we found that there was an increase in the odds
of asthma for those who use e-cigarettes that were quite
similar to that for combustible cigarettes, although the association was not statistically significant.
Limitations of this study are inherent in its cross-sectional design and implementation via telephone survey. The
data were self-reported, and we were unable to confirm
asthma diagnosis or obtain other relevant information, such
as age of onset. Additionally, we do not know the length of
ENDS use, the frequency that respondents consumed these
products, or if their use preceded onset of asthma symptoms. There also may be bias in reporting ENDS or cigarette
use, as participants from some demographic groups, due to
social desirability bias, may not acknowledge use.
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Additionally, other risk factors, such as occupational exposures, could not be accounted for, as these questions are not
included in the standard BRFSS questionnaire. Additional
limitations relate to the exclusion of respondents outside the
18–30 age range, which was necessary due to very low current use rates of ENDS among older adults. Lastly, our
results may not be generalizable to other states, as they are
derived from a population-based sample of Kentucky adults.

Conclusion
This study found preliminary evidence that ENDS use modestly contributes to asthma burden, but further work exploring this in a larger sample is needed.
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